|
|
Blood, 1 October 2006, Vol. 108, No. 7, pp. 2428-2434.
Prepublished online as a Blood First Edition Paper on June 6, 2006; DOI 10.1182/blood-2006-04-018341.
 Previous Article | Table of Contents | Next Article 
RED CELLS
In vivo tumor growth is inhibited by cytosolic iron deprivation caused by the expression of mitochondrial ferritin
Guangjun Nie,
Guohua Chen,
Alex D. Sheftel,
Kostas Pantopoulos, and
Prem Ponka
From the Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, and the Departments of Physiology and Medicine, McGill University, Montreal, QC, Canada.
Mitochondrial ferritin (MtFt) is a mitochondrial iron-storage protein whose function and regulation is largely unknown. Our previous results have shown that MtFt overexpression markedly affects intracellular iron homeostasis in mammalian cells. Using tumor xenografts, we examined the effects of MtFt overexpression on tumor iron metabolism and growth. The expression of MtFt dramatically reduced implanted tumor growth in nude mice. Mitochondrial iron deposition in MtFt-expressing tumors was directly observed by transmission electron microscopy. A cytosolic iron starvation phenotype in MtFt-expressing tumors was revealed by increased RNA-binding activity of iron regulatory proteins, and concomitantly both an increase in transferrin receptor levels and a decrease in cytosolic ferritin. MtFt overexpression also led to decreases in total cellular heme content and heme oxygenase-1 levels. In addition, elevated MtFt in tumors was also associated with a decrease in total aconitase activity and lower frataxin protein level. In conclusion, our study shows that high MtFt levels can significantly affect tumor iron homeostasis by shunting iron into mitochondria; iron scarcity resulted in partially deficient heme and iron-sulfur cluster synthesis. It is likely that deprivation of iron in the cytosol is the cause for the significant inhibition of xenograft tumor growth.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
"Iron mining" to inhibit tumor growth
- Des R. Richardson and David B. Lovejoy
Blood 2006 108: 2140.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
T. Kozu, G. Iinuma, Y. Ohashi, Y. Saito, T. Akasu, D. Saito, D. B. Alexander, M. Iigo, T. Kakizoe, and H. Tsuda
Effect of Orally Administered Bovine Lactoferrin on the Growth of Adenomatous Colorectal Polyps in a Randomized, Placebo-Controlled Clinical Trial
Cancer Prevention Research,
November 1, 2009;
2(11):
975 - 983.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Campanella, E. Rovelli, P. Santambrogio, A. Cozzi, F. Taroni, and S. Levi
Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia
Hum. Mol. Genet.,
January 1, 2009;
18(1):
1 - 11.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Wallander, K. B. Zumbrennen, E. S. Rodansky, S. J. Romney, and E. A. Leibold
Iron-independent Phosphorylation of Iron Regulatory Protein 2 Regulates Ferritin during the Cell Cycle
J. Biol. Chem.,
August 29, 2008;
283(35):
23589 - 23598.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Whitnall, Y. S. Rahmanto, R. Sutak, X. Xu, E. M. Becker, M. R. Mikhael, P. Ponka, and D. R. Richardson
The MCK mouse heart model of Friedreich's ataxia: Alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation
PNAS,
July 15, 2008;
105(28):
9757 - 9762.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Santambrogio, G. Biasiotto, F. Sanvito, S. Olivieri, P. Arosio, and S. Levi
Mitochondrial Ferritin Expression in Adult Mouse Tissues
J. Histochem. Cytochem.,
November 1, 2007;
55(11):
1129 - 1137.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Chen, C. Fillebeen, J. Wang, and K. Pantopoulos
Overexpression of iron regulatory protein 1 suppresses growth of tumor xenografts
Carcinogenesis,
April 1, 2007;
28(4):
785 - 791.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
